According to Haite Biotech, on July 9, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Administration for Disease Control and Prevention jointly issued the “National Catalogue of Essential Medicines”. The new drug catalogue will be officially implemented on September 1, 2026. Two of Wuhan Hite Biopharmaceutical Co., Ltd.'s products, trimetazidine hydrochloride tablets and injectable esomeprazole sodium, were selected into the “National Essential Drug Catalogue”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.